BioVille
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
BioVille - overview
Established
2010
Location
-, -, Belgium
Primary Industry
Business Support Services
About
BioVille is a health and care sector hub providing tailored workspaces and facilities that support specialized research and development for startups and organizations. BioVille, founded in 2010 and headquartered in Belgium, operates as a comprehensive health and care sector hub. In December 2010, LRM Limburg Investment Company invested in BioVille. The company has engaged in a single investment deal since its inception, emphasizing its commitment to fostering innovation within the health and care industries.
BioVille serves organizations and startups in the health and care sectors by offering a variety of workspaces and facilities tailored for specialized research and development. The company provides office spaces, flexible workstations, laboratories, and experimental areas, catering to healthcare innovators, digital health companies, researchers, and corporate teams. Strategically located within the Euregio, BioVille promotes cross-border collaboration with clients in Belgium, the Netherlands, and Germany. In 2022, BioVille reported a revenue of USD 1.
19 mn and an EBITDA of USD 65,455. The company generates income primarily through the rental of office spaces, laboratories, and meeting rooms, alongside various supportive services. Clients typically engage on a subscription basis for long-term rentals or pay one-time fees for event spaces, facilitating partnerships with research organizations and healthcare companies. BioVille aims to expand its services by introducing new workspace solutions tailored for upcoming trends in health technology.
Plans are underway to enter new markets in France and Luxembourg by 2023, leveraging recent funding from the December 2010 investment by LRM Limburg Investment Company to support these initiatives. The company is focused on enhancing its facilities and expanding its footprint to foster innovation in the health sector.
Current Investors
Primary Industry
Business Support Services
Sub Industries
Business Support Services
Website
www.bioville.be
Total Amount Raised
Subscriber access only
BioVille - timeline of key events
BioVille - financials
| Fiscal Year Ended | Dec 31, 2010 | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 162,261 | 355,100 | 694,390 | 728,533 | 730,361 | 591,254 | 483,743 | 771,379 | 829,995 | 852,425 | 912,345 | 982,885 | - | - | - |
| % Revenue Growth (YoY) | - | 118.8% | 95.5% | 4.9% | 0.3% | (19.0%) | (18.2%) | 59.5% | 7.6% | 2.7% | 7.0% | 7.7% | - | - | - |
| EBITDA (USD) | (122,948) | (71,223) | 75,946 | 120,946 | 177,121 | 27,686 | (1,149) | 299,968 | 324,607 | 305,207 | 310,732 | 203,983 | - | - | - |
| Operating Income (USD) | (311,850) | (277,354) | (165,360) | (138,728) | (145,801) | (344,400) | (359,354) | (74,391) | (100,494) | (110,051) | (130,975) | (290,130) | - | - | - |
| Operating Margin | (192.2%) | (78.1%) | (23.8%) | (19.0%) | (20.0%) | (58.2%) | (74.3%) | (9.6%) | (12.1%) | (12.9%) | (14.4%) | (29.5%) | - | - | - |
| % EBITDA Margin | (75.8%) | (20.1%) | 10.9% | 16.6% | 24.3% | 4.7% | (0.2%) | 38.9% | 39.1% | 35.8% | 34.1% | 20.8% | - | - | - |
| NET Income (USD) | (492,380) | (493,923) | (273,484) | (172,872) | (250,899) | (445,528) | (475,575) | (126,626) | (133,332) | (137,532) | (134,307) | (253,164) | - | - | - |
| % Net Margin | (303.4%) | (139.1%) | (39.4%) | (23.7%) | (34.4%) | (75.4%) | (98.3%) | (16.4%) | (16.1%) | (16.1%) | (14.7%) | (25.8%) | - | - | - |
BioVille - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.